Chapare hemorrhagic fever

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:319244A96.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Chapare hemorrhagic fever (also called Chapare virus disease) is a rare and serious viral illness caused by the Chapare virus, which belongs to a family of viruses called arenaviruses. This disease was first identified in 2004 in the Chapare region of Bolivia, South America. Like other hemorrhagic fevers, it attacks the body's ability to control bleeding and can damage multiple organs at the same time. The virus spreads to people mainly through contact with infected rodents or their droppings, urine, or saliva. There is also evidence that the virus can spread from person to person, especially in healthcare settings where protective equipment may not be fully available. This makes it a concern not just for people living in rural areas near rodents, but also for healthcare workers caring for sick patients. Symptoms usually start within one to two weeks of exposure and can include fever, headache, muscle pain, vomiting, and in severe cases, bleeding from the gums, nose, or other parts of the body. The illness can become life-threatening quickly. There are no approved vaccines or specific antiviral drugs for Chapare hemorrhagic fever at this time. Treatment focuses on supportive care, such as managing fluids, controlling bleeding, and treating complications as they arise. Early medical attention is critical for survival.

Key symptoms:

High feverSevere headacheMuscle and joint painStomach pain and vomitingDiarrheaBleeding from the gums or noseSkin rashSwelling of the faceEye redness or irritationExtreme tiredness and weaknessLow blood pressureBleeding under the skin (bruising easily)Confusion or altered mental state in severe cases

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Chapare hemorrhagic fever.

View clinical trials →

No actively recruiting trials found for Chapare hemorrhagic fever at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Chapare hemorrhagic fever community →

No specialists are currently listed for Chapare hemorrhagic fever.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Chapare hemorrhagic fever.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Chapare hemorrhagic feverForum →

No community posts yet. Be the first to share your experience with Chapare hemorrhagic fever.

Start the conversation →

Latest news about Chapare hemorrhagic fever

No recent news articles for Chapare hemorrhagic fever.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How was the diagnosis of Chapare hemorrhagic fever confirmed, and what tests were used?,What supportive treatments are being used, and what are the goals of each?,Is there any experimental antiviral treatment available, and would I qualify for it?,What signs should I or my family watch for that would mean I need emergency care right away?,How long is the recovery period, and what limitations should I expect after leaving the hospital?,Are my family members or caregivers at risk of catching this virus, and what precautions should they take?,Should this case be reported to public health authorities, and will there be follow-up monitoring?

Common questions about Chapare hemorrhagic fever

What is Chapare hemorrhagic fever?

Chapare hemorrhagic fever (also called Chapare virus disease) is a rare and serious viral illness caused by the Chapare virus, which belongs to a family of viruses called arenaviruses. This disease was first identified in 2004 in the Chapare region of Bolivia, South America. Like other hemorrhagic fevers, it attacks the body's ability to control bleeding and can damage multiple organs at the same time. The virus spreads to people mainly through contact with infected rodents or their droppings, urine, or saliva. There is also evidence that the virus can spread from person to person, especially

How is Chapare hemorrhagic fever inherited?

Chapare hemorrhagic fever follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Chapare hemorrhagic fever typically begin?

Typical onset of Chapare hemorrhagic fever is adult. Age of onset can vary across affected individuals.